LAST PRICE - AT THE CLOSE
EMRAF is UP 9% since the begininning of the year
EMRAF is DOWN -2% BELOW 20 day SMA
EMRAF is UP 9% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.3721
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 34.3734
INCOME TO DEBT RATIO: 0.03
 |
THE STOCK IS 22.4% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS UP 9% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS UP 18% OVER THE PAST 12 MONTHS |
 |
EMRAF IS DOWN -0% OVER THE PAST 1 MONTH |
 |
1% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0 over the last hour |
 |
EMRAF is up 1.2% over the last 5 days |
 |
EMRAF is 0.7 above its 8 day SMA |
| $0.00 | DAY |
$0.00 |
| $40.07 |  PREVIOUS DAY |
$40.77 |
| $39.19 |  WEEK |
$44.11 |
| $39.19 | MONTH |
$44.11 |
| $32.00 | YEAR |
$44.11 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
